撰写论文的点滴体会分析.pptVIP

What are others What are ours In previous studies, increasing age and the presence of coexisting conditions have been associated with a higher risk of bleeding complications. Our findings also suggest that fibrinolysis is associated with a lower risk of bleeding in younger patients than in patients over 75 years of age, although this difference was not significant. In a recently published trial of tenecteplase treatment in patients with ST-segment elevation myocardial infarction, there were no cases of intracranial hemorrhage when the dose was reduced by 50% in patients 75 years of age or olde